The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Lexeo Therapeutics Inc shares valued at $20,491 were sold by Townsend Richard Nolan on Dec 10 ’24. At $8.20 per share, Townsend Richard Nolan sold 2,500 shares. The insider’s holdings dropped to 120,695 shares worth approximately $0.82 million following the completion of this transaction.
Also, Richard Nolan Townsend purchased 2,500 shares, netting a total of over 20,600 in proceeds.
Before that, CHOLMONDELEY PAULA H had added 15,000 shares to its account. In a trade valued at $104,852, the Director bought Lexeo Therapeutics Inc shares for $6.99 each. Upon closing the transaction, the insider’s holdings increased to 15,000 shares, worth approximately $0.21 million.
As published in their initiating research note from Robert W. Baird on June 13, 2024, Lexeo Therapeutics Inc [LXEO] has been an Outperform and the price target has been revised to $28. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of November 28, 2023, Stifel has initiated its “Buy” rating for LXEO. Earlier on November 28, 2023, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for LXEO stock.
Analyzing LXEO Stock Performance
During the last five days, there has been a surge of approximately 3.65%. Over the course of the year, Lexeo Therapeutics Inc shares have jumped approximately 3.65%. Shares of the company reached a 52-week high of $7.66 on 01/06/25 and a 52-week low of $6.50 on 01/02/25. A 50-day SMA is recorded $7.32, while a 200-day SMA reached $11.39. Nevertheless, trading volume fell to 0.19 million shares from 0.18 million shares the previous day.
Support And Resistance Levels for Lexeo Therapeutics Inc (LXEO)
According to the 24-hour chart, there is a support level at 6.64, which, if violated, would cause prices to drop to 6.47. In the upper region, resistance lies at 7.12. The next price resistance is at 7.43. RSI (Relative Strength Index) is 47.36 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.44, which suggests the price will decrease in the coming days. Percent R is at 45.41%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
